Magic mushroom therapy targets chronic PTSD in new trial
NCT ID NCT06386003
First seen Feb 01, 2026 · Last updated Jun 08, 2026 · Updated 18 times
Summary
This study tests whether psilocybin, the active ingredient in magic mushrooms, combined with a specific type of talk therapy can help people with long-term post-traumatic stress disorder (PTSD). The trial will include 15 adults with moderate to severe PTSD who are not taking psychiatric medications. The goal is to see if this approach is safe, tolerable, and effective at reducing PTSD symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PTSD are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St. Michael's Hospital, Unity Health Toronto
Toronto, Ontario, Canada
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.